Facebook tracking pixel

Coming Soon

S10.AI's Next-Generation Telehealth Platform

G62.1
ICD-10-CM
Alcoholic Neuropathy

Understanding Alcoholic Neuropathy, also known as Alcoholic Polyneuropathy or Alcohol-Induced Neuropathy, is crucial for accurate healthcare documentation and medical coding. This page provides information on diagnosis, clinical presentation, and ICD-10 codes related to alcohol-related peripheral neuropathy for medical professionals and coding specialists. Learn about symptoms, treatment, and the impact of alcohol abuse on the peripheral nervous system.

Also known as

Alcoholic Polyneuropathy
Alcohol-Induced Neuropathy

Diagnosis Snapshot

Key Facts
  • Definition : Nerve damage caused by excessive alcohol use, leading to pain, numbness, and weakness.
  • Clinical Signs : Tingling, burning, or prickling sensations in hands and feet. Muscle weakness, cramps, and loss of coordination.
  • Common Settings : Primary care, neurology clinics, pain management centers, and addiction treatment facilities.

Related ICD-10 Code Ranges

Complete code families applicable to AAPC G62.1 Coding
G62.1

Alcoholic polyneuropathy

Nerve damage caused by excessive alcohol use.

F10

Mental and behavioural disorders due to alcohol

Covers various mental and behavioral issues related to alcohol use.

G60-G64

Polyneuropathies and other disorders of the peripheral nervous system

Includes various disorders affecting the peripheral nerves, including polyneuropathies.

Code-Specific Guidance

Decision Tree for

Follow this step-by-step guide to choose the correct ICD-10 code.

Is the neuropathy directly due to alcohol use?

Code Comparison

Related Codes Comparison

When to use each related code

Description
Nerve damage from excessive alcohol use.
Nerve damage from vitamin B1 deficiency.
Generalized symmetrical peripheral nerve damage.

Documentation Best Practices

Documentation Checklist
  • Document symmetrical distal paresthesias.
  • Record pain, burning, or numbness in extremities.
  • Note muscle weakness or atrophy, if present.
  • Detail alcohol use history and duration.
  • Specify if other causes ruled out (e.g., diabetes).

Coding and Audit Risks

Common Risks
  • Unspecified Alcohol Use

    Coding requires specificity of alcohol use (acute, chronic, in remission). Unspecified use may lead to downcoding or claim denial.

  • Comorbidity Overlap

    Diabetic and alcoholic neuropathy may coexist. Accurate coding requires distinct documentation of both conditions to avoid underpayment.

  • Documentation Deficiency

    Insufficient documentation linking neuropathy directly to alcohol use can lead to coding errors and compliance issues.

Mitigation Tips

Best Practices
  • Stop alcohol use. Code G62.1, ICD-10-CM.
  • Thiamine supplements. Document B1 deficiency, ICD-10-CM E51.8
  • Pain management. Code G89.29, ICD-10-CM. Monitor opioid use.
  • Physical therapy for improved mobility. Document progress in medical record.
  • Nutritional counseling. Code Z71.3, ICD-10-CM. Improve overall health.

Clinical Decision Support

Checklist
  • 1. Chronic alcohol use documented (ICD-10: F10.2x)?
  • 2. Symmetrical distal paresthesias/pain (sensory exam)?
  • 3. Reduced reflexes/muscle weakness (motor exam)?
  • 4. Other causes excluded (diabetes, B12 deficiency)?
  • 5. Consider EMG/NCS if diagnosis uncertain.

Reimbursement and Quality Metrics

Impact Summary
  • Alcoholic Neuropathy (ICD-10-CM G62.1): Coding accuracy impacts reimbursement for neuropathy and related complications.
  • Proper coding of G62.1 and associated conditions (e.g., pain, gait disorders) maximizes hospital revenue.
  • Accurate Alcoholic Neuropathy diagnosis coding improves quality metrics reporting for substance use disorders.
  • Coding quality directly affects hospital reimbursement for alcohol-related complications and resource utilization.

Streamline Your Medical Coding

Let S10.AI help you select the most accurate ICD-10 codes. Our AI-powered assistant ensures compliance and reduces coding errors.

Frequently Asked Questions

Common Questions and Answers

Q: What are the most effective diagnostic approaches for differentiating Alcoholic Neuropathy from other peripheral neuropathies in a clinical setting?

A: Differentiating Alcoholic Neuropathy from other peripheral neuropathies requires a multi-faceted approach. Begin with a thorough clinical history focusing on alcohol consumption patterns, nutritional deficiencies (especially thiamine), and other potential contributing factors like diabetes or vitamin B12 deficiency. Electrodiagnostic studies, including nerve conduction studies and electromyography, can reveal axonal damage characteristic of alcoholic neuropathy. However, these findings can be similar in other neuropathies, so consider comparing clinical features and nerve biopsy in complex cases. Serum thiamine levels can help identify deficiency contributing to the neuropathy, but normal levels dont rule it out. Explore how a combination of history, electrodiagnostic studies, and assessment of nutritional deficiencies can enhance diagnostic accuracy. Consider implementing a standardized assessment protocol for all patients presenting with peripheral neuropathy to ensure a comprehensive diagnostic workup.

Q: How can clinicians effectively manage pain and other debilitating symptoms associated with Alcoholic Neuropathy while addressing the underlying cause?

A: Effective management of Alcoholic Neuropathy addresses both symptom relief and the underlying cause. Pain management strategies often involve gabapentinoids like gabapentin or pregabalin as first-line therapy, and tricyclic antidepressants or serotonin-norepinephrine reuptake inhibitors (SNRIs) can be helpful adjuncts. Topical agents like capsaicin cream can offer localized pain relief. Critically, address alcohol cessation through counseling and support groups, as ongoing alcohol use exacerbates the neuropathy. Nutritional support, especially thiamine supplementation, is essential to correct deficiencies and promote nerve recovery. Learn more about integrating pharmacological pain management with alcohol cessation programs and nutritional support to improve patient outcomes. Consider implementing a multidisciplinary approach involving neurologists, addiction specialists, and registered dietitians for comprehensive care.

Quick Tips

Practical Coding Tips
  • Code G62.2 for Alcoholic Polyneuropathy
  • Document alcohol use details
  • Specify upper/lower limb involvement
  • Query physician if cause unclear
  • Consider Wernicke-Korsakoff (G32.8) if present

Documentation Templates

Patient presents with complaints consistent with alcoholic neuropathy, also known as alcoholic polyneuropathy or alcohol-induced neuropathy.  Symptoms include progressive numbness, tingling, burning pain, and muscle weakness, predominantly in the extremities, particularly the feet and hands.  The patient reports a history of chronic and excessive alcohol consumption.  On physical examination, diminished deep tendon reflexes, distal sensory loss to pinprick and vibration, and mild distal muscle atrophy were noted.  Differential diagnoses considered include diabetic neuropathy, vitamin B12 deficiency neuropathy, and other toxic neuropathies.  Laboratory tests, including a complete blood count (CBC), comprehensive metabolic panel (CMP), vitamin B12 levels, and thyroid stimulating hormone (TSH), were ordered to rule out other etiologies.  The patient's symptoms, coupled with the history of alcohol abuse and neurological findings, support the diagnosis of alcoholic neuropathy.  The primary treatment plan focuses on alcohol cessation counseling and support, along with pain management strategies.  Pharmacological interventions may include gabapentin or pregabalin for neuropathic pain.  Patient education regarding the importance of nutritional support, particularly thiamine supplementation, was provided.  Referral to a neurologist and a registered dietitian is recommended for further evaluation and management of the neuropathy and nutritional deficiencies related to chronic alcohol use.  Follow-up appointment scheduled in four weeks to assess response to treatment and monitor symptom progression.  ICD-10 code G62.2 is considered for this encounter.